New Rochelle, NY, March 21, 2018--Researchers report that racial disparities in HIV control (viral load) exist even when patients have equal access to care, as shown in a study of black and white HIV-infected patients treated in the Veterans Administration (VA) health system. The study, which identified specific factors that contributed to these differences, is published in AIDS Patient Care and STDs, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the AIDS Patient Care and STDs (https:/
The article "Patient and Facility Correlates of Racial Differences in Viral Control for Black and White Veterans with HIV Infection in the Veterans Administration" was coauthored by Mary Vaughan Sarrazin, PhD, Iowa City VA Medical Center and University of Iowa (Iowa City) and colleagues from VA Palo Alto Health Care System (CA), Stanford University (CA), ENRM Veterans Affairs Medical Center (Bedford, MA), and Boston University School of Public Health (MA). The researchers determined that more than half of the disparity in viral control between black and white veterans could be attributed to differences in adherence to combination antiretroviral therapy (cART).
"This is an especially critical issue given the widening disparity in incidence of new HIV infections between African Americans and other racial/ethnic groups," says Editor-in-Chief Jeffrey Laurence, MD, Professor of Medicine, Weill Cornell Medical College, New York, NY.
About the Journal
AIDS Patient Care and STDs is the leading peer-reviewed journal dedicated to diagnostics and therapeutics for providing optimal care for HIV/AIDS patients. Published monthly online with open access options and in print and online, the Journal spans the full spectrum of adult and pediatric HIV disease, diagnosis, treatment, prevention, and education, enabling clinicians to keep pace with the latest developments in this evolving field. Complete tables of content and a sample issue may be viewed on the AIDS Patient Care and STDs website.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including AIDS Research and Human Retroviruses, LGBT Health, Transgender Health, Viral Immunology, and Journal of Palliative Medicine. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals and books is available on the Mary Ann Liebert, Inc., publishers website.
Mary Ann Liebert, Inc. 140 Huguenot St., New Rochelle, NY 10801-5215 http://www.